• Home
  • Ab&B Bio-Tech CO.,LTD.JS

Ab&B Bio-Tech CO.,LTD.JS

About Ab&B Bio-Tech CO.,LTD.JS

Ab&B Bio-Tech CO.,LTD.JS has a registered capital of 360 million yuan, with a phase I project investment of 500 million yuan, a phase II project investment of 500 million yuan, and a new phase III investment of 2 billion yuan. It is committed to the research and development, registration application, and industrialized production and sales of innovative vaccines for human use, aiming at internatio...

Read more Show less
Certifications
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    250 - 499
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contact info
Show contact info Hide contact info

Products from Ab&B Bio-Tech CO.,LTD.JS (1)

  • Quadrivalent Subunit Influenza Vaccine

    Product Quadrivalent Subunit Influenza Vaccine

    As the latest generation of influenza vaccines produced in China,Ab&B Bio-Tech CO.,LTD.JS Hui'erkangxin contains four types of influenza viruses: H1N1 A-type, H3N2 A-type, B-type BV, and B-type BY.This vaccine adopts a safer subunit process, milder extraction agents, and more efficient injectors. ...